Nevertheless, the possibility to perform a meta-analysis allowed us to demonstrate the presence of a significant correlation between ABCG2 c.421C>A and imatinib plasma Ctrough in CML and GIST patients. Here, ABCG2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.